Uliginosin B, a Possible New Analgesic Drug, Acts by Modulating the Adenosinergic System

Uliginosin B (ULI) is a natural acylphloroglucinol that has been proposed as a new molecular scaffold for developing analgesic and antidepressant drugs. Its effects seem to be due to its ability to increase monoamines in the synaptic cleft by inhibiting their neuronal uptake without binding to their...

Descripción completa

Detalles Bibliográficos
Autores principales: Stolz, Eveline Dischkaln, da Costa, Paola Fontoura, Medeiros, Liciane Fernandes, Souza, Andressa, Battastini, Ana Maria Oliveira, von Poser, Gilsane Lino, Bonan, Carla, Torres, Iraci L. S., Rates, Stela Maris Kuze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819114/
https://www.ncbi.nlm.nih.gov/pubmed/27087824
http://dx.doi.org/10.1155/2016/5890590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819114/
https://www.ncbi.nlm.nih.gov/pubmed/27087824
http://dx.doi.org/10.1155/2016/5890590

Ejemplares similares